Biocon Biologics
Milind Dalal has extensive experience in the biopharmaceutical industry, with a strong focus on commercial strategy, business management, and partnership development. With a background in chemical engineering and an MBA from INSEAD, Milind has held key roles at Biocon Biologics, Shell, Genentech, and other companies. Milind's expertise includes managing commercial operations, developing contracting strategies, and leading cross-functional teams. Milind has played a crucial role in the commercialization of biosimilars in advanced markets and has a proven track record of success in driving business growth and strategic alliances.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics